Andrés Redondo

No ORCID on file · 5 papers in corpus · active 2019-2026

Study types

  • article 3
  • other 2

Condition tags

  • mesh:D004715 3
  • endometriosis 3
  • adenomyosis 1
other 2026
Impact of endometriosis on survival outcomes in ovarian cancer patients: a pilot study
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2026.115110

OBJECTIVES: The aim of our study is to investigate the percentage of ovarian cancer (OC) patients with concomitant endometriosis and its distribution across histological subtypes, and to assess whether the presence of endometriosis influenc…

article 2023
Evaluation of Immune Infiltrates in Ovarian Endometriosis and Endometriosis-Associated Ovarian Cancer: Relationship with Histological and Clinical Features
International journal of molecular sciences ·doi:10.3390/ijms241512083

Background: the association between ovarian endometriosis (OE) and endometriosis-associated ovarian cancer (EAOC) is extensively documented, and misfunction of the immune system might be involved. The primary objective of this study was to …

article 2022
Prognostic markers of inflammation in endometrioid and clear cell ovarian cancer
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1136/ijgc-2022-003353
article 2021
Tumor infiltrating lymphocytes (TILs) in endometrioid and clear cell ovarian carcinoma: Characterization, association with mismatch repair system deficiency and endometriosis, and prognostic implications.
·doi:10.1200/jco.2021.39.15_suppl.e17549

e17549 Background: In contrast to high-grade serous ovarian cancer, relationship between tumor infiltrating lymphocytes (TILs) with endometrioid (EC) and clear cell ovarian carcinomas (CC) are less known. However, these tumors are thought t…

other 2019
Myoinvasive Pattern as a Prognostic Marker in Low-Grade, Early-Stage Endometrioid Endometrial Carcinoma
Cancers ·doi:10.3390/cancers11121845

Low-grade and early Federation for Gynecology and Obstetrics (FIGO) stage endometrioid endometrial carcinomas (EEC) have an excellent prognosis. However, approximately 10% of patients develop recurrence, which cannot be correctly predicted …